Vertex Pharmaceuticals Vanza Triple Shows Promise in Treating Cystic Fibrosis
On February 5, 2024, Vertex Pharmaceuticals made a groundbreaking announcement regarding their Phase 3 pivotal trials of the vanzacaftor/tezacaftor/deutivacaftor (vanza ...